What if the key to treating chronic diseases like rheumatoid arthritis wasn't drugs but a tiny electrical device? That's the promise of vagus nerve stimulation (VNS), a groundbreaking therapy that holds the potential to transform how we approach conditions like asthma, heart disease, diabetes, obesity, and even depression and other mental health issues. On this 20-Minute Health Talk, we explore the fascinating science and remarkable potential of VNS with two leading experts: Kevin Tracey, MD, president & CEO of the Feinstein Institutes for Medical Research and the founder of bioelectronic medicine; and Murthy Simhambhatla, PhD, president & CEO of SetPoint Medical, a company pioneering cutting-edge VNS devices.

Together, they discuss the history of VNS, its applications today and the potential to address a wide range of other inflammatory conditions, from multiple sclerosis to inflammatory bowel disease (IBD). They also dive into the early results of a SetPoint-led study using VNS to treat rheumatoid arthritis, which Dr. Tracey believes could be the tipping point in this over 30-year odyssey.